Brain-wide glymphatic enhancement and clearance in humans assessed with MRI G Ringstad, LM Valnes, AM Dale, AH Pripp, SAS Vatnehol, KE Emblem, ... JCI insight 3 (13), 2018 | 399 | 2018 |
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation TT Batchelor, ER Gerstner, KE Emblem, DG Duda, J Kalpathy-Cramer, ... Proceedings of the national academy of sciences 110 (47), 19059-19064, 2013 | 388 | 2013 |
Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion AG Sorensen, KE Emblem, P Polaskova, D Jennings, H Kim, ... Cancer research 72 (2), 402-407, 2012 | 338 | 2012 |
Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy KE Emblem, K Mouridsen, A Bjornerud, CT Farrar, D Jennings, RJH Borra, ... Nature medicine 19 (9), 1178-1183, 2013 | 277 | 2013 |
Magnetic resonance imaging provides evidence of glymphatic drainage from human brain to cervical lymph nodes PK Eide, SAS Vatnehol, KE Emblem, G Ringstad Scientific reports 8 (1), 7194, 2018 | 262 | 2018 |
Glioma Grading by Using Histogram Analysis of Blood Volume Heterogeneity from MR-derived Cerebral Blood Volume Maps1 KE Emblem, B Nedregaard, T Nome, P Due-Tonnessen, JK Hald, ... Radiology 247 (3), 808-817, 2008 | 196 | 2008 |
Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium G Seano, HT Nia, KE Emblem, M Datta, J Ren, S Krishnan, J Kloepper, ... Nature biomedical engineering 3 (3), 230-245, 2019 | 178 | 2019 |
Lessons from anti–vascular endothelial growth factor and anti–vascular endothelial growth factor receptor trials in patients with glioblastoma C Lu-Emerson, DG Duda, KE Emblem, JW Taylor, ER Gerstner, ... Journal of Clinical Oncology 33 (10), 1197-1213, 2015 | 175 | 2015 |
Advanced magnetic resonance imaging of the physical processes in human glioblastoma J Kalpathy-Cramer, ER Gerstner, KE Emblem, OC Andronesi, B Rosen Cancer research 74 (17), 4622-4637, 2014 | 173 | 2014 |
A fully automated method for quantitative cerebral hemodynamic analysis using DSC–MRI A Bjørnerud, KE Emblem Journal of Cerebral Blood Flow & Metabolism 30 (5), 1066-1078, 2010 | 162 | 2010 |
T1- and T*2-Dominant Extravasation Correction in DSC-MRI: Part I—Theoretical Considerations and Implications for Assessment of Tumor Hemodynamic Properties A Bjornerud, AG Sorensen, K Mouridsen, KE Emblem Journal of Cerebral Blood Flow & Metabolism 31 (10), 2041-2053, 2011 | 146 | 2011 |
A generic support vector machine model for preoperative glioma survival associations KE Emblem, MC Pinho, FG Zöllner, P Due-Tonnessen, JK Hald, ... Radiology 275 (1), 228-234, 2015 | 119 | 2015 |
Quantitative analyses of T2-weighted MRI as a potential marker for response to somatostatin analogs in newly diagnosed acromegaly A Heck, KE Emblem, O Casar-Borota, J Bollerslev, G Ringstad Endocrine 52, 333-343, 2016 | 105 | 2016 |
Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma J Kalpathy-Cramer, V Chandra, X Da, Y Ou, KE Emblem, A Muzikansky, ... Journal of neuro-oncology 131, 603-610, 2017 | 90 | 2017 |
SVM-based glioma grading: optimization by feature reduction analysis FG Zöllner, KE Emblem, LR Schad Zeitschrift für medizinische Physik 22 (3), 205-214, 2012 | 85 | 2012 |
Automatic glioma characterization from dynamic susceptibility contrast imaging: Brain tumor segmentation using knowledge‐based fuzzy clustering KE Emblem, B Nedregaard, JK Hald, T Nome, P Due‐Tonnessen, ... Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2009 | 85 | 2009 |
Histogram analysis of MR imaging–derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes KE Emblem, D Scheie, P Due-Tonnessen, B Nedregaard, T Nome, ... American journal of neuroradiology 29 (9), 1664-1670, 2008 | 82 | 2008 |
A fully automated deep learning network for brain tumor segmentation CGB Yogananda, BR Shah, M Vejdani-Jahromi, SS Nalawade, ... Tomography 6 (2), 186, 2020 | 77 | 2020 |
Vessel calibre—a potential MRI biomarker of tumour response in clinical trials KE Emblem, CT Farrar, ER Gerstner, TT Batchelor, RJH Borra, BR Rosen, ... Nature reviews Clinical oncology 11 (10), 566-584, 2014 | 67 | 2014 |
Bevacizumab reduces permeability and concurrent temozolomide delivery in a subset of patients with recurrent glioblastoma ER Gerstner, KE Emblem, K Chang, B Vakulenko-Lagun, YF Yen, ... Clinical Cancer Research 26 (1), 206-212, 2020 | 64 | 2020 |